What is it about?
Tremendous sucess has been recently made in understanding the underlying mechanisms and the nature of Langerhans cell histiocytosis (LCH), a rare disease of the monocyte, macrophage and dendritic cell system. This paper summarizes new findings (e.g. gene mutations and affected cellular pathways) pertinent to disease biology , as well as their implications for monitoring of disease activity and targeted treatment of patients with LCH.
Featured Image
Read the Original
This page is a summary of: Insights into the pathogenesis of Langerhans cell histiocytosis: the development of targeted therapies, ImmunoTargets and Therapy, October 2016, Dove Medical Press,
DOI: 10.2147/itt.s91058.
You can read the full text:
Contributors
The following have contributed to this page